PLXP PLx Pharma Inc.

5.98
-0.25  -4%
Previous Close 6.23
Open 6.23
Price To Book -11.72
Market Cap 52,346,331
Shares 8,753,567
Volume 5,912
Short Ratio
Av. Daily Volume 7,405

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data did not meet endpoints - October 25, 2016.
Locilex
Mild infections of diabetic foot ulcers
sNDA filing due late 2019.
Aspertec
Aspirin - cardiovascular and stroke patients patients

Latest News

  1. PLx Pharma on Track for VAZALORE Regulatory Pathway
  2. Edited Transcript of PLXP earnings conference call or presentation 10-May-19 12:30pm GMT
  3. PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference
  4. Could The PLx Pharma Inc. (NASDAQ:PLXP) Ownership Structure Tell Us Something Useful?
  5. PLx Pharma Inc. Reports First Quarter 2019 Results
  6. PLx Pharma (PLXP) Expected to Beat Earnings Estimates: Should You Buy?
  7. PLx Pharma Inc. to Discuss 2019 First Quarter Financial Results on May 10, 2019 Conference Call
  8. Edited Transcript of PLXP earnings conference call or presentation 8-Mar-19 1:30pm GMT
  9. PLx Pharma Inc. Reports Fourth Quarter 2018 Results
  10. PLx Pharma Inc. to Discuss 2018 Fourth Quarter and Full Year Financial Results on March 8, 2019 Conference Call
  11. PLx Pharma Inc. Announces Completion of $15 Million Convertible Preferred Stock Financing
  12. PLx Pharma Inc. Announces Adjournment of Special Meeting of Stockholders
  13. PLx Pharma's Capital Raise More Dilutive Than Expected, Raymond James Says
  14. PLx Pharma Inc. Announces $15 Million Convertible Preferred Stock Financing
  15. PLx Pharma Inc. to Present at Biotech Showcase 2019
  16. Edited Transcript of PLXP earnings conference call or presentation 9-Nov-18 1:30pm GMT
  17. PLx Pharma Inc. Reports Third Quarter 2018 Results
  18. PLx Pharma Inc. to Discuss 2018 Third Quarter Financial Results on November 9, 2018 Conference Call
  19. Who Really Owns PLx Pharma Inc (NASDAQ:PLXP)?